Ege University, Faculty of Medicine, Department of Medical Biology, Izmir, Turkey.
Near East University, Vocational School of Health Services, Medical Biology Department, Lefkosa, Cyprus.
Gene. 2019 Mar 1;687:261-271. doi: 10.1016/j.gene.2018.11.049. Epub 2018 Nov 17.
Paclitaxel, which isolated from Taxus brevifolia, is recently started to be used against prostate cancer treatment and it is a very effective compound against cancer. In this study, we aimed to test the synergistic effect of two plant active compounds (sulphoraphane (SFN) and silymarin (SILY)) and several endemic plant species from Turkey (such as Phlomis leucophracta, Rubia davisiana, Alkanna tinctoria), which are known to have anticarcinogenic effect on androgen-independent PC3 and DU145, and androgen-dependent VCaP prostate cancer cell lines, with paclitaxel on the expression of cell cycle signaling and apoptosis regulator genes. Herbal substances and endemic herbal extracts were combined with Paclitaxel drug. IC doses were identified as real-time online. The most effective synergistic doses were determined according to isobologram analysis. The apoptotic effects of effective combined doses were evaluated by TUNEL, Annexin V, and JC-1 methods. Apoptotic and/or cell cycle arrest effects of confirmed combined doses on the expression of genes in these pathways were assessed by real-time online. Endemic plant extracts (Alkanna tinctoria, Phlomis leucophracta and Rubia davisiana, IC < 220 μg/ml) and herbal substances (SILY, and SFN IC < 130 μM) indicated antiproliferative and apoptotic effects in prostate cancer cell lines. They testified to the synergistic effect of paclitaxel with endemic plant extracts (Combination Index CI, ED < 0.41). The combinations, which indicate the synergistic effect was increased to the Bax/Bcl‑2 ratio by suppressing Bcl‑2 gene expression into the prostate cancer cell lines. Besides, they increased the expression of TNFRSF10A, TNFRSF1A, CHEK1, CDKN1A, CDKN2B, CDK8, CDKN3 and CASP14 and decreased BAD, CDK5RAP1, CDC20, cyclin H, CDK5RAP1, CDC20. The effective doses of paclitaxel were reduced and G2/M arrest was induced by the endemic plant extracts and herbal substances that indicate a synergistic effect with paclitaxel. By using different combination of herbal extracts or active substances with paclitaxel, more economical and efficient treatment strategies can be developed.
紫杉醇是从短叶红豆杉中分离出来的,最近开始用于前列腺癌的治疗,它是一种对抗癌症非常有效的化合物。在这项研究中,我们旨在测试两种植物活性化合物(萝卜硫素(SFN)和水飞蓟素(SILY))和几种来自土耳其的特有植物物种(如白屈菜、山萝卜和滨藜)的协同作用,这些植物已知对雄激素非依赖性 PC3 和 DU145 以及雄激素依赖性 VCaP 前列腺癌细胞系具有抗癌作用,与紫杉醇联合使用可影响细胞周期信号和凋亡调节基因的表达。草药物质和特有草药提取物与紫杉醇药物联合使用。通过实时在线确定 IC 剂量。根据等效应线分析确定最有效的协同剂量。通过 TUNEL、Annexin V 和 JC-1 方法评估有效联合剂量的凋亡作用。通过实时在线评估确认联合剂量对这些通路中基因表达的凋亡和/或细胞周期阻滞作用。特有植物提取物(滨藜、白屈菜和山萝卜,IC < 220 μg/ml)和草药物质(SILY 和 SFN,IC < 130 μM)在前列腺癌细胞系中表现出抗增殖和凋亡作用。它们证明了紫杉醇与特有植物提取物的协同作用(组合指数 CI,ED < 0.41)。这些组合通过抑制 Bcl-2 基因表达将 Bax/Bcl-2 比值增加到前列腺癌细胞系中。此外,它们增加了 TNFRSF10A、TNFRSF1A、CHEK1、CDKN1A、CDKN2B、CDK8、CDKN3 和 CASP14 的表达,并降低了 BAD、CDK5RAP1、CDC20、cyclin H、CDK5RAP1 和 CDC20 的表达。特有植物提取物和草药物质降低了紫杉醇的有效剂量并诱导 G2/M 期阻滞,与紫杉醇具有协同作用。通过使用不同的草药提取物或与紫杉醇具有协同作用的活性物质组合,可以开发更经济有效的治疗策略。